IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 90 filers reported holding IGM BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $696,824 | +80.9% | 83,452 | +100.0% | 0.00% | – |
Q2 2023 | $385,131 | +48.4% | 41,726 | +120.9% | 0.00% | – |
Q1 2023 | $259,590 | -53.1% | 18,893 | -42.0% | 0.00% | -100.0% |
Q4 2022 | $553,829 | -12.5% | 32,559 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $633,000 | +7.8% | 32,559 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $587,000 | -32.5% | 32,559 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $870,000 | -40.7% | 32,559 | -34.9% | 0.00% | 0.0% |
Q4 2021 | $1,467,000 | -46.0% | 50,031 | +21.2% | 0.00% | -66.7% |
Q3 2021 | $2,715,000 | +11.5% | 41,286 | +15.4% | 0.00% | +50.0% |
Q2 2021 | $2,434,000 | -17.4% | 35,786 | -6.8% | 0.00% | -33.3% |
Q1 2021 | $2,946,000 | +10.5% | 38,408 | +27.2% | 0.00% | 0.0% |
Q4 2020 | $2,666,000 | +74.7% | 30,201 | +46.1% | 0.00% | +50.0% |
Q3 2020 | $1,526,000 | -16.0% | 20,674 | -16.9% | 0.00% | -33.3% |
Q2 2020 | $1,816,000 | +37.2% | 24,874 | +5.5% | 0.00% | +50.0% |
Q1 2020 | $1,324,000 | +20.6% | 23,574 | -18.1% | 0.00% | 0.0% |
Q4 2019 | $1,098,000 | +114.9% | 28,774 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $511,000 | – | 28,774 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |